Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Medtronic
Covington
Merck
Fish and Richardson
Farmers Insurance
Julphar
Citi

Generated: December 9, 2018

DrugPatentWatch Database Preview

Rescinnamine - Generic Drug Details

« Back to Dashboard

What are the generic sources for rescinnamine and what is the scope of rescinnamine patent protection?

Rescinnamine is the generic ingredient in two branded drugs marketed by Panray and Pfizer, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for rescinnamine.

Summary for rescinnamine
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 1
Bulk Api Vendors: 15
Patent Applications: 901
DailyMed Link:rescinnamine at DailyMed
Synonyms for rescinnamine
11,17-Dimethoxy-18-[[1-oxo-3-3,4,5-trimethoxyphenyl)-2-propenyl]oxy]-3,20-yohimban-16-carboxylic acid methyl ester
11,17alpha-Dimethoxy-18beta-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-3beta,20alpha-yohimban-16beta-carboxylic acid methyl ester
15676-43-4
15676-44-5
24815-24-5
25460-29-1
28821-79-6
3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-11,17-alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxycinnamate (ester)
3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-11,17-alpha-dimethoxy-,methyl ester, 3,4,5-trimethoxycinnamate (ester)
3,4,5-Trimethoxycinnamic acid, methyl reserpate
3,4,5-Trimethoxycinnamoyl methyl reserpate
3,4,5-Trimethylcinnamic acid, ester with methyl reserpate
3,4,5-Trimethylcinnamoyl methyl reserpate
3,5-Trimethoxycinnamic acid, methyl reserpate
3,5-Trimethoxycinnamoyl methyl reserpate
3.beta., 18.beta.-hydroxy-11,17.alpha.-dimethoxy-, methyl ester, 3,4,5-trimethoxycinnamate (ester)
3beta,20alpha-Yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxycinnamate (ester)
3beta,20alpha-Yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxycinnamate (ester), (E)-
4-25-00-01323 (Beilstein Handbook Reference)
412909-15-0
522-78-1
84-34-4
ACon1_002115
AI3-52763
Anapral
Anaprel
Anaprel (TN)
Apolon
Apoterin
Apoterin S
Benz[g]indolo[2, 1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-3-hydroxy-2,11-dimethoxy-, methyl ester, 3,4,5-trimethoxycinnamate
BPBio1_000392
BRD-K52930707-001-02-2
BRD-K52930707-001-04-8
BRN 0075328
BSPBio_000356
C06540
C35H42N2O9
Cartric
CCRIS 4711
CHEBI:28572
CHEBI:92923
CHEMBL1668
Cinamine
Cinatabs
Cinnaloid
Cinnasil
Cinnasil (TN)
D00198
D0G8NJ
DR003419
EINECS 246-471-8
GTPL7098
HMS1569B18
HMS2096B18
HMS2234E08
HSDB 2176
LS-1060
MEGxp0_001952
methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
METHYL (1R,15S,17R,18R,19S,20S)-6,18-DIMETHOXY-17-{[(2E)-3-(3,4,5-TRIMETHOXYPHENYL)PROP-2-ENOYL]OXY}-3,13-DIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4(9),5,7-TETRAENE-19-CARBOXYLATE
methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.0;{2,10}.0;{4,9}.0;{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate
methyl (3beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-({(2E)-3-[3,4,5-tris(methyloxy)phenyl]prop-2-enoyl}oxy)yohimban-16-carboxylate
methyl 11,17alpha-dimethoxy-18beta-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3beta,20alpha-yohimban-16beta-carboxylate
Methyl 18-O-(3,4,5-trimethoxycinnamoyl)reserpate
Methyl 18beta-hydroxy-11,17alpha-dimethoxy-3beta,20alpha-yohimban-16beta-carboxylate
Methyl 1alpha,2beta,3alpha,4,4aalpha,5,7,8,13,13bbeta,14,14aalpha-dodecahydro-2alpha,11-dimethoxy-3beta-(3,4,5-trimethoxycinnamoyloxy)benz(g)indolo(2,3-a)quinolizine-1beta-carboxylate
Methyl reserpate 3,4,5-trimethoxycinnamic acid ester
Methyl trimethoxycinnamoylreserpate
MLS002153878
Moderil
Moderil (TN)
MolPort-001-742-634
Normorescina
NP-011016
NSC 15628
NSC-15628
NSC15628
O-(3,4,5-Trimethoxy-trans-cinnamoyl) methyl reserpate
Paresinan
PL051802
Prestwick_558
Prestwick2_000568
Prestwick3_000568
Q6W1F7DJ2D
Raupyrol
Raurescin
Raurescine
Recinnamine
Recitensina
Rescaloid
Rescamin
Rescidan
Rescin
Rescinamina
Rescinamina [INN-Spanish]
Rescinnamin
Rescinnamina
Rescinnamina [DCIT]
Rescinnamine (JAN/INN)
Rescinnamine (VAN)
Rescinnamine [BAN:INN:JAN]
Rescinnamine [INN:BAN:JAN:NF]
Rescinnaminum
Rescinnaminum [INN-Latin]
Rescinpal
Rescisan
Rescitens
Resealoid
Resepinine (C35 alkaloid)
Reserpic acid methyl ester 3,4,5-trimethoxycinnamate
Reserpinene
Reserpinin
Reserpinine
Reserpinine (C35 alkaloid)
Reserpinine (VAN)
Resipal
Reskinnamin
Rozex
SCHEMBL181966
Scinnamina
SMR001233232
Tenamine
Trimethoxy cinnamoyl reserpate de methyl
Trimethoxy cinnamoyl reserpate de methyl [French]
Trimethoxycinnamoyl methyl reserpate
Tsuruselpi S
Tsuruselpi S (TN)
Tuareg
UNII-Q6W1F7DJ2D
Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-(((2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-
Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-oxy)-, methyl ester, (3beta,16beta,17alpha,18beta(E),20alpha)-
Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-
Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-[[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]oxy]-, methyl ester, (3b,16b,17a,18b,20a)-
Yohimban-16-carboxylic acid,17-dimethoxy-18-[[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]oxy]-, methyl ester, (3.beta.,16.beta.,17.alpha.,18.beta.,20.alpha.)-
Yohimban-16-carboxylicacid,11,17-dimethoxy-18-[[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]oxy]-,methyl ester, (3b,16b,17a,18b,20a)-
ZINC4097185

US Patents and Regulatory Information for rescinnamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer MODERIL rescinnamine TABLET;ORAL 010686-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer MODERIL rescinnamine TABLET;ORAL 010686-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Panray CINNASIL rescinnamine CAPSULE;ORAL 084736-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
US Department of Justice
Baxter
McKinsey
Johnson and Johnson
Chinese Patent Office
Fish and Richardson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.